Table 1.
Patient features and their effects on all-cause mortality
| Variables | Descriptions | HRa | 95 CIa | P a |
|---|---|---|---|---|
| Demographics | ||||
| Age (year) b | 86(82–90) | 1.08 | 1.03–1.14 | 0.003 |
| Males (%) | 187(85.4) | 0.83 | 0.37–1.84 | 0.642 |
| BMI (kg/m2) c | 24.1(3.8) | 0.95 | 0.88–1.03 | 0.189 |
| Diseases | ||||
| Congestive heart failure/ventricular function< 40% (%) | 102(46.6) | 2.45 | 1.39–4.33 | 0.002 |
| Hypertension (%) | 170(77.6) | 1.30 | 0.63–2.66 | 0.476 |
| Diabetes mellitus (%) | 78(35.6) | 1.95 | 1.14–3.34 | 0.015 |
| Stroke/TIA (%) | 20(9.1) | 0.81 | 0.29–2.25 | 0.690 |
| Vascular diseases (%) | 51(23.3) | 1.22 | 0.66–2.24 | 0.526 |
| Clinical presentation | ||||
| Heart rate (bpm) b | 74(64–84) | 1.02 | 1.01–1.03 | 0.003 |
| SBP (mmHg) b | 132(123–141) | 1.00 | 0.98–1.02 | 0.666 |
| DBP (mmHg) b | 70(64–76) | 0.98 | 0.95–1.01 | 0.223 |
| Laboratory results | ||||
| Hemoglobin (g/L) b | 123.0(107.0–136.0) | 0.96 | 0.95–0.97 | < 0.001 |
| Plasma albumin (g/L) c | 37.7(4.2) | 0.82 | 0.78–0.87 | < 0.001 |
| FBG (mmol/L) b | 5.5(4.9–6.3) | 1.17 | 1.10–1.25 | < 0.001 |
| Cholesterol (mmol/L) b | 3.7(3.2–4.3) | 0.88 | 0.64–1.21 | 0.434 |
| HDL-c (mmol/L) b | 1.0(0.9–1.2) | 0.13 | 0.05–0.32 | < 0.001 |
| LDL-c (mmol/L) b | 2.1(1.6–2.5) | 0.87 | 0.59–1.28 | 0.489 |
| Uric acid (mmol/L) b | 352.4(270.1–441.1) | 1.00 | 1.00–1.01 | 0.021 |
| GFR (ml/min/1.73 m2) b | 65.8(52.6–78.6) | 0.97 | 0.96–0.98 | < 0.001 |
| NT-proBNP (pg/mL) b | 1333.0(463.4–3101.8) | 1.84 | 1.53–2.22 | < 0.001 |
Notes: aunivariate Cox regression analyses; bmedian (interquartile range); cmean (standard deviation)
Abbreviations: HR hazard ratio, CI confidential interval, BMI body mass index, TIA transient ischemic attack, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, GFR glomerular filtration rate, NT-proBNP N-terminal pro-brain natriuretic peptide